why choose us

Clinical Trials Search

Showing 12,550 of 132,366 result(s)
The Impact of an Adaptive Patient-centered Web Application on Medication Optimization in HFrEF Patients

Status: Completed

Condition: Heart Failure

Interventions: Adaptive medication recommendations that can be shared with the participants HF provider.

Date: 2023-05-01

Impact of Neurochecks on Sleep in Critically Ill Adults

Status: Completed

Condition: Cerebral Aneurysm

Interventions: Randomized to hourly or every-other-hour examinations

Date: 2023-05-01

Early Feasibility Study Evaluating the 3P-100 Device in Subjects With PH-ILD

Status: Completed

Condition: Hypertension, Pulmonary

Interventions: eNOfit system delivering iNO

Date: 2023-05-01

Shoulder Injury Rate and Risk Among CrossFit Participants in Greece. ?fficacy of an Innovative Prevention Program.

Status: ACTIVE_NOT_RECRUITING

Condition: Sports Injury

Interventions:

Date: 2023-05-01

Crizanlizumab Alone or in Combination With Nivolumab for Glioblastoma and Melanoma With Brain Metastases

Status: NOT_YET_RECRUITING

Condition: Advanced Glioblastoma

Interventions: 5 mg;kg solution for injection

Date: 2023-05-01

A Retrospective Study on Extranodal Lymphoma or Lymphoma of Rare Pathological Types

Status: NOT_YET_RECRUITING

Condition: Lymphoma

Interventions: No interventions need to be specified for this study

Date: 2023-05-01

Interventional Strategy in Tackling Emerging Non-alcoholic Fatty Liver Disease in Childhood Obesity

Status: COMPLETED

Condition: Obesity

Interventions: The 50 mg of vitamin E isomers in the TRF included 17.1 mg of ?-tocopherol ,18.28 mg of ?- tocotrienol, 2.02 mg of ?-tocotrienol, 22.3 mg of ?-tocotri

Date: 2023-05-01

Evaluating the Efficacy and Safety of the VERAFLO™ Dressing Kit for Wound Bed Preparation in Open Wounds

Status: Completed

Condition: Wound Healing

Interventions:

Up to 170 subjects who meet the eligibility criteria will be randomized to the investigational group or control group at the ratio 1:1.

Subje

Date: 2023-05-01

Effect of a Progressive Treadmill Training Protocol for Parkinson's Disease

Status: Completed

Condition: Parkinson Disease

Interventions: The protocol will include three sessions per week for 8 weeks of gait training using C-Mill with AVR applications.
An anchoring system will preve

Date: 2023-05-01

A Real-world Study of Obinutuzumab-based Therapy for Previously Untreated FL

Status: Completed

Condition: Follicular Lymphoma

Interventions: Obinutuzumab IV infusion will be administered as per the schedule specified in the respective arm.

Date: 2023-05-01